Form 4: Boston Scientific CEO Michael Mahoney Reports Stock Transactions
SEC Form 4 Filing
Michael Mahoney, Chairman, President & CEO of Boston Scientific, reports acquisition and disposal of common stock and restricted stock units.
Summary
- On February 12, 2025, Michael F. Mahoney, Chairman, President & CEO of Boston Scientific, reported transactions involving Boston Scientific common stock and restricted stock units.
- Mahoney acquired 13,704 shares of common stock through the vesting of restricted stock units.
- Simultaneously, 6,626 shares were disposed of to cover tax obligations at a price of $105.77 per share.
- Following these transactions, Mahoney directly owns 1,626,951 shares of common stock and indirectly owns 201,478 shares through a trust.
- He also holds 41,112 restricted stock units, which will vest in four equal annual installments starting February 12, 2025.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reflects routine transactions related to executive compensation. There are no indications of unusual or concerning activity.
Positives
- The vesting of restricted stock units indicates a continued alignment of Mahoney's interests with those of the company and its shareholders.
Future Outlook
The restricted stock units will vest in four equal annual installments beginning on February 12, 2025, indicating future stock issuances to the reporting person.
Industry Context
Form 4 filings are routine disclosures for corporate insiders and provide transparency into their trading activities, which can be informative for investors.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they are part of standard executive compensation practices.
Key Dates
| Date | Description |
|---|---|
| 02/12/2025 | Date of stock transactions (acquisition and disposal) and vesting of restricted stock units. |
| 02/14/2025 | Date of signature for the Form 4 filing. |
| 02/12/2028 | Expiration date of the restricted stock units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.